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ABSTRACT 
Synchronous tumours can be found all along the entire neuraxis, however, some 
lesions are far less likely to coexist. One of these extremely rare associations is 
between GH-pituitary adenomas and suprasellar meningiomas. A wide spectrum of 
transcranial and transsphenoidal approaches were described in the literature for 
either sellar, suprasellar and parasellar lesions, but no agreement has been reached 
for the cases of simultaneous occurring lesions. 
We present a rare case of a woman with GH-secreting pituitary adenoma and 
concomitant suprasellar meningioma. The strategy chosen was sequential 
transsphenoidal surgeries. However, after the first surgery, the remaining tumour 
mass did not mobilize as expected due to gravity, hence we decided to perform a 
transcranial subfrontal unilateral approach. Surprisingly, the second surgery revealed 
a different histopathological result. 
Association of a GH-pituitary adenoma and suprasellar meningioma is very rare, only 
17 cases being reported in the relevant literature so far.  Different authors prefer 
different strategies, ranging from only transsphenoidal to simultaneous 
transsphenoidal and transcranial approaches, but no general consensus was 
established. 
In conclusion, the existence of synchronous tumours of the sellar region should be 
taken into account when imaging studies reveal an intracranial mass developing both 
sellar and suprasellar. The surgical strategy should be tailored to every specific 
patient and experience of the neurosurgeon. 
INTRODUCTION 
Synchronous tumors are found along the entire neuraxis, however 
some lesions are far less likely to coexist (1). One of these unlikely 
associations is between pituitary adenomas and suprasellar menin- 
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giomas. Few cases have been reported in literature, 
most of the pituitary tumors being GH secreting 
adenomas. (1) However, a syndrome has yet to be 
defined consisting of this association, and, with the 
exception of the previously radio-treated pituitary 
adenomas that develop subsequent meningiomas, 
no pathophysiological connection exists. 
Even though each type of tumor has distinct 
radiological findings, there are cases in which they 
can easily be misdiagnosed or even confused for one 
single lesion. This rare occurrence must be taken into 
account by neurosurgeons planning tumor resection 
in such cases. A wide spectrum of transcranial and 
transsphenoidal approaches have been described in 
literature for either sellar, suprasellar and parasellar 
lesions, but no agreement has been reached for the 
cases of simultaneous occurring lesions. (2) 
The purpose of this article is to present a rare 
case of a simultaneous GH secreting pituitary 
adenoma and a supradiafragmatic meningioma, the 
strategy behind the surgical approach and review of 
literature. 
 
CASE PRESENTATION 
A 57 years old woman, with history of stage II 
hypertension, type II diabetes mellitus, NYHA II heart 
failure was admitted with intense headache, visual 
field disturbances and hormonal disturbances 
(elevated GH levels: IGF-1 = 98 ng/ml, N = 10 ng/ml). 
The cerebral CT scan showed a contrast enhancing 
sellar mass which extended suprasellar, slightly 
eccentric to the left. (Figure 1) 
The presumed diagnosis was GH-secreting 
pituitary macroadenomma with suprasellar 
extension. We decided to perform surgery via 
transsfenoidal approach. Due to large size of the 
tumor and high risk of rupturing the sellar 
diaphragm, only partial resection was performed 
and a second transsfenoidal surgery was scheduled 
for the upcoming three months. The rationale was 
that the suprasellar part of a tumor originating in the 
sellar region will gravitationally fall in the sella over 
the next three months, thus enabling a second 
minimally invasive surgery. 
The first histopathological exam was acidophilic 
pituitary adenoma with capsular invasion. (Figure 2) 
Initial postoperative outcome was uneventful, 
without any additional neurological deficits. 
After three months, the cerebral CT scan showed 
a surprising stationary suprasellar tumor. (Figure 3)  
We changed our initial strategy, and we decided to 
operate the tumor via the subfrontal approach on 
the nondominant side (right). Intraoperative we 
found a suprasellar meningioma. We achieved 
tumor complete resection, with no intraoperative 
incidents.  
The second histopathological exam revealed 
meningothelial meningioma with transitional 
components. (Figure 4) After removal of the 
suprasellar tumor, visual field impairment improved. 
The patient required substitute hormonal therapy 
for transient diabetes insipidus for the first three 
months, which was gradually lowered in dosage. At 
three months postop, CT showed complete tumor 
removal and the patient was hormonally stable. Even 
if standard post-surgical strategy is to administer 
oral corticoids, these were interrupted after only one 
month, and no further hormonal therapy was 
required. 
The particularity of the case was simultaneous 
development of a GH-secreting pituitary 
macroadenoma and suprasellar meningioma, a rare 
association of two types of histological tumors, with 
no apparent link between them. 
 
 
 
 
 
Figure 1. Cerebral CT scan showing a sellar and suprasellar 
contrast enhanced tumor. 
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Figure 2. Acidophilic pituitary adenoma; HE; 40x. 
 
 
 
Figure 3. Cerebral CT scan, performed 3 months after the first 
surgery, showing suprasellar contrast enhanced tumor with no 
sellar tumor. 
 
 
 
 
 
Figure 4. Meningothelial meningioma with transitional 
components; HE; a. 20x; b. 40x. 
 
REVIEW OF LITERATURE 
MESH terminology consists of two different 
situations which describe simultaneous 
development of brain tumors. Thus, one can 
encounter either collision tumors, in which case one 
tumor infiltrates the other one, or coincidental 
tumors, tumors being synchronous, but with 
different histogenesis, being situated one next to the 
other or at a distance. (3) 
We performed a search in PubMed and Google 
Scholar for simultaneous occurring brain tumors out 
of which one would be a pituitary adenoma and we 
found 43 publications and a total of 63 patients. (1) 
Furthermore, a search of similar cases to ours found 
that the rare situation of simultaneous development 
of a pituitary adenoma and suprasellar or sphenoid 
wing meningioma has been reported in 32 cases. (4) 
Moreover, only 17 cases of strictly suprasellar 
meningiomas were described in the literature, our 
case being the 18th. (1) 
 
DISCUSSIONS 
Tumors of the sellar region have mesenchymal, 
neural or epithelial origin, along with cystic and 
inflammatory processes. Out of all these tumors, 
pituitary adenomas are the most common, 
accounting for about 10-15% of all intracranial 
tumors. (5) Most of the patients treated in our clinic 
present with both endocrine symptoms, but also 
intracranial hypertension and optic chiasm 
symptoms due to large size of the tumor. Thus, most 
of the patients suffer from macroadenomas (> 10 
mm) at the time of diagnosis, and most of the tumors 
extending beyond the sella turcica, either parasellar 
or suprasellar. 
The existence of simultaneous pituitary adenoma 
and supradiafragmatic meningioma is a very rare 
situation. Search of relevant literature performed in 
PubMed and Google Scholar revealed only 17 other 
cases, ours being the 18th. (1) 
Even though a plethora of possible mechanisms 
have been forwarded in relation to multiple brain 
tumors occurring simultaneously and having 
different histology origins, none have been widely 
recognized by the neurosurgery community. 
While some authors suggest a common receptor 
activator that triggers both lesions, others believe 
that one of the tumors might secrete a growth factor 
responsible for the initiation of aberrant cell growth 
in the second tumor. Although growth hormone 
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secreting adenomas have been suggested to induce 
arachnoid cell transformation, this hypothesis has 
yet to be confirmed. (6) 
Other authors consider favorable factors for 
synchronously developing adenoma and 
meningioma variables such as genetic factors, prior 
trauma or surgery and even exposure to offending 
biochemical substances. (7) 
It is essential to distinguish between cases of 
pituitary adenoma with a suprasellar component, 
and cases of a co-existing sellar adenoma and 
suprasellar meningioma, because different surgical 
strategies might be adequate for these two different 
situations. (2) This is particularly difficult, because in 
most of the times the two lesions are 
indistinguishable from a radio-imaging point of view, 
our case did not show any pathognomonic imaging 
characteristic. 
Most authors prefer to perform both tumor 
resections in either one surgical procedure, or 
combined transsphenoidal and transcranial 
approach under the same single general anesthesia. 
However, sometimes this might not be possible, and 
a decision must be made on which lesion to perform 
resection on first. Surgical strategy is tailored 
according to the symptomatic lesion. So, in such 
cases it must be seen to whom the symptoms are 
due. Both tumors were located in the same area, 
sellar and suprasellar region and both can cause 
slightly similar neurological complains.  Headache is 
a nonspecific symptom, visual fields deficits are 
common findings in both pituitary macroadenomas 
and suprasellar meningiomas, but hormonal 
imbalances are specific for a pituitary adenoma. So, 
in cases when lesions cannot be resected using the 
same approach, the surgeon must first operate the 
symptomatic tumor.  
Regarding the existence of an agreement as to 
the best surgical approach to be used, we could only 
find one: use the best approach tailored to the 
specific case of the patient. Therefore, some authors 
prefer to perform a transsphenoidal approach for 
both the lesions (3), others use a combined approach 
under the same anesthesia, others prefer a two 
timed transsphenoidal (4), transcranial, and so on. 
Two-stage surgery is not an uncommon practice 
for large pituitary adenomas. In our case, both sellar 
and suprasellar components were considered to be 
part of the same pituitary macroadenoma. The 
treatment of choice for pituitary adenomas is tumor 
resection via transphenoidal route. During 
transsphenoidal surgery the sellar part of the tumor 
is resected, and the soft suprasellar component 
descends, with the aid of gravity and CSF pulsation 
and develop itself to the surgeon. When the tumor is 
more firm this cannot happen during surgery. 
Vigorous attempts to pull the suprasellar tumor into 
the sella can be dangerous, due to possibility of 
adherence to neurovascular structures. More sellar 
diaphragm can be teared, leading to postoperative 
CSF fistula. In such cases a two-stage 
transsphenoidal surgery can be performed, because 
after a period of time of a few months the suprasellar 
will descend and through planned elective surgery 
the tumor can be complety resected via same 
surgical approach with minimal risks. Even more, 
first histopathological examination confirmed the 
nature of the tumor as being GH-secreting pituitary 
adenoma. That was the rationale for our decision not 
to extend the resection to the suprasellar 
component, but rather consider a second 
transsphenoidal approach 3 months later, in order to 
allow the rest of the tumor to gravitationally descend 
in the sella. However, the CT scan at 3 months 
showed a stationary suprasellar component. The 
decision was made to perform subfrontal approach 
in order remove this component. This second lesion 
turned out to be a meningioma.   
This case perfectly illustrates the need for 
approaching every sellar tumor through the path 
that offers the most advantages. Thus, a 
transsfenoidal approach would not have allowed the 
surgeon to resect the suprasellar component 
without major risks, whilst a subfrontal approach 
would not have been possible to resect the entire 
sellar component. 
Overall, the patient had favorable outcome, 
because he harbored two benign, slow-growing 
tumors.  
 
CONCLUSIONS 
Synchronous GH-secreting macroadenoma and 
suprasellar meningioma developing simultaneously 
in the sellar and suprasellar region are very rare 
findings. In selected cases, both minimally invasive 
transsfenoidal approach and transcranial 
microsurgical approach must be considered 
simultaneously in order to achieve complete 
resection. Moreover, the existence of two different 
lesions developing in the same region should be 
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considered in all the cases of pituitary adenomas 
with a suprasellar component. Further research is 
needed with genetic profile of patients with 
synchronous tumors.  
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